Individual factors influencing the response to a beta-adrenergic blocking agent given alone and in combination with a diuretic in arterial hypertension

1979 ◽  
Vol 16 (5) ◽  
pp. 311-317 ◽  
Author(s):  
O. Lederballe Pedersen ◽  
E. Mikkelsen
Keyword(s):  
Arterial Hypertension ◽  
Blocking Agent ◽  
Individual Factors ◽  
Beta Adrenergic ◽  
Factors Influencing ◽  
Adrenergic Blocking

scholarly journals Nebivolol for treatment patients with arterial hypertension

2014 ◽  
Vol 11 (3) ◽  
pp. 83-87
Author(s):  
O M Mikheeva ◽  
I A Komisarenko
Keyword(s):  
Blood Pressure ◽  
Arterial Hypertension ◽  
Oxidative Degradation ◽  
Blocking Agent ◽  
Blocking Effect ◽  
Beta Adrenergic ◽  
Adrenergic Blocking

Beta-adrenergic blocking agent is included in the group of primary agentsfor treatment of patients with AH. In the pathogenesis of AH,one of the main causes leading to raisingthe blood pressure isendothelial dysfunction.Correction ofendothelial dysfunctionis AH treatment strategic aim.Nebivololis a cardioselectivethird-generationvasodilatingβ-adrenergic blocking agent, which is in addition toβ-adrenergic blocking effect, can alsoincrease endogenousproduction of NOin the endothelial cellsdue to the decreasing of oxidative degradation. As a result,nebivololprovides positivehemodynamic effects on patients with AH, decreasingperipheral resistanceandblood pressure.

Evaluation of a new beta-adrenergic blocking agent, carteolol, based on metabolic responses in rats—I

1976 ◽  
Vol 25 (16) ◽  
pp. 1837-1842 ◽  
Author(s):  
Seiji Morita ◽  
Yasuo Irie ◽  
Yuichi Saitoh ◽  
Hideaki Kohri
Keyword(s):  
Blocking Agent ◽  
Metabolic Responses ◽  
Beta Adrenergic ◽  
Adrenergic Blocking

scholarly journals 14C-labelling of a new .BETA.-adrenergic blocking agent (S-596)

RADIOISOTOPES ◽  
1982 ◽  
Vol 31 (2) ◽  
pp. 101-103 ◽  
Author(s):  
Akira YOSHITAKE ◽  
Hideyuki GOMI ◽  
Iwao NAKATSUKA
Keyword(s):  
Blocking Agent ◽  
Beta Adrenergic ◽  
14C Labelling ◽  
Adrenergic Blocking

Synthesis of the .beta.-adrenergic blocking agent timolol from optically active precursors

1976 ◽  
Vol 41 (19) ◽  
pp. 3121-3124 ◽  
Author(s):  
Leonard M. Weinstock ◽  
Dennis M. Mulvey ◽  
Roger. Tull
Keyword(s):  
Blocking Agent ◽  
Optically Active ◽  
Beta Adrenergic ◽  
Adrenergic Blocking
Sign in / Sign up

Export Citation Format

Share Document